Detalhe da pesquisa
1.
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients.
Int J Cancer;
153(6): 1217-1226, 2023 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37243480
2.
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
Br J Cancer;
128(7): 1286-1293, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36717671
3.
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort.
Int J Cancer;
151(8): 1355-1366, 2022 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35666525
4.
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Oncologist;
25(9): e1355-e1362, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32618068
5.
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer.
Clin Cancer Res;
2024 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38656833
6.
TP53-associated early breast cancer: new observations from a large cohort.
J Natl Cancer Inst;
2024 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38569880
7.
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.
J Clin Pathol;
2023 Jun 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37344170
8.
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.
Clin Cancer Res;
29(17): 3429-3437, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37417941
9.
The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling.
Cancers (Basel);
14(17)2022 Aug 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36077738
10.
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2- breast cancer: Available evidence and clinical implications.
Cancer Treat Rev;
102: 102323, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34896969
11.
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?
Cancer Treat Rev;
110: 102462, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36087503
12.
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series.
Pathol Res Pract;
233: 153872, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35390634
13.
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
Neuro Oncol;
24(12): 2146-2158, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35609559
14.
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
NPJ Breast Cancer;
8(1): 66, 2022 May 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35595761
15.
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial.
EBioMedicine;
85: 104320, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36374768
16.
Evolution of HER2-low expression from primary to recurrent breast cancer.
NPJ Breast Cancer;
7(1): 137, 2021 Oct 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34642348
17.
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
NPJ Breast Cancer;
7(1): 101, 2021 Aug 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34341356
18.
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
ESMO Open;
5(5): e000843, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33020219
19.
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.
NPJ Breast Cancer;
7(1): 149, 2021 Nov 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34819500